- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
High prevalence of Sarcopenic Obesity among survivors of childhood ALL-study
Obesity is recognized as a common chronic health problem among survivors of childhood cancer; is also known to increase risk of metabolic syndrome and cardiovascular disease. As Acute Lymphoblastic leukemia(ALL) is commonest childhood cancer, researchers from Rajiv Gandhi Cancer Institute, Delhi aimed to study prevalence of childhood obesity and sarcopenia among survivors of childhood ALL.
In this case control study, 65 cases who were survivors of ALL (<18yrs at diagnosis) were analysed at 5 years of completion of therapy and matched with healthy sibling controls. All the cases received BFM protocol for treatment of ALL. Dual energy Xray absorbometry(DEXA) and BMI were used to study body fat composition.
Key findings of the study are:
1. The mean body fat percentage (BF%) was significantly higher among ALL survivors as compared to sibling controls(p=0.001).
2. Obesity was observed among 21.5 %( 14 out of 65) cases and overweight among 55% of cases at follow up.
3. Also body fat mass index(BFMI) was significantly higher among survivors of ALL(p<0.001)
4. High prevalence of sarcopenic obesity was observed among survivors which was not seen in controls.
There are several studies predicting obesity but the indicators used were BMI, height, weight, waist-hip circumference which underestimate the prevalence of obesity as it cannot identify normal or underweight individuals with high body fat. Henceforth Payal et all in the present study used DEXA to quantify adiposity and sarcopenia which are considered better predictors of obesity.
Authors say-"Prevalence of obesity and overweight was not influenced by study participants' nutritional status at diagnosis, since thin and normally nourished children treated for ALL were equally affected".
It been concluded that-since obesity and sarcopenia are believed to be forerunners of cardio-metabolic syndrome, the results of study emphasize on early recognition and aggressive preventive strategies on this sub-population of children.
Source: Malhotra P, Kapoor G, Jain S, Jain S, Sharma A. Obesity and Sarcopenia in Survivors of Childhood Acute Lymphoblastic Leukemia. Indian Pediatr. 2021 May 15;58(5):436-440.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751